Altogether these data show that early complement components, particularly C1q and C3, are present in both the developing brain and normal aging brain independent of the breakdown of the blood-brain barrier, while the synthesis of complement proteins by neurons and glia is increased in the diseased brain, including in MS. The gene discussed is C3; the disease is myeloid sarcoma.